Abstract:Two recent pivotal studies offer an opportunity to shift the thinking on population strategies to reduce dietary sodium intake to improve cardiovascular health. The SSaSS (Salt Substitute and Stroke Study), a cluster-randomized controlled study in high-risk persons in rural China was the first randomized clinical trial in a community setting of dietary sodium reduction with a potassium enriched salt substitute to report a reduction not only in blood pressure, but, in stroke, heart disease events, and total mortality. 1 The sodium intervention was a potassium-enriched salt substitute and was provided for food preservation and food preparation in homes in individuals with high risk for cardiovascular disease. See related article, pp 2188–2198 A second pivotal study is reported in this issue of Hypertension. 2 The researchers modeled the effects of a population-wide intervention in India replacing salt with a potassium enriched salt substitute as used in the China study. The modeling study evaluated the impact of this intervention on cardiovascular disease morbidity and mortality as well as adverse effects from hyperkalemia both in the general population and in those with undiagnosed chronic kidney disease. A similar modeling study was performed on the Chinese population as a follow-up of the SSaSS study. 1 Results from the India study suggest that nation wide salt substitution could prevent 8% to 14% of cardiovascular events annually (240 000–315 000 lives saved per year in the total population). While intervention strategies have focused on reducing sodium intake, the importance of increasing potassium needs consideration, both the potential for harm from hyperkalemia and whether increased potassium intake reduces cardiovascular disease risk. Concern about the possibility of hyperkalemia with the use of potassium-enriched salt substitutes has likely reduced enthusiasm for its use as a population strategy to lower blood pressure and reduce cardiovascular disease risk. The SSaSS study addressed this issue carefully, evaluating reports of risk and benefit of the intervention in the general population. Importantly, the India study evaluated both risk and benefit in persons with undiagnosed chronic kidney disease. The India modeling study demonstrates a strong benefit in those with and without chronic kidney disease. The small morbidity and mortality from hyperkalemia in the chronic kidney disease group is overwhelmed by the large benefit on cardiovascular health. In the SSaSS study, as well as most studies on the effect of potassium-enriched salt substitutes on blood pressure, the focus has been on the benefit of sodium reduction. Sorting out the potential contribution of increasing potassium intake in these studies has been a matter of interest for decades. 3 Increasing potassium intake without lowering sodium intake has a modest effect on lowering blood pressure. In the early 1990s, Langford 4 raised the question of whether there was cardiovascular protection from potassium independent of the effect on blood pressure. Since then, multiple studies have identified the benefit of higher potassium intake along with sodium reduction lowering blood pressure as well as the risk of cardiovascular disease, especially stroke. 3 Understanding the relative contribution of decreasing dietary sodium versus increasing dietary potassium could be important in designing interventions for future studies and in clinical implementation. Another key issue, study design, will be considered in deciding whether these 2 studies dramatically shift thinking on adopting potassium-enriched salt substitution as a population strategy for cardiovascular disease prevention. The study from India is a modeling study using the most rigorous methods for this study design. Modeling studies have gained widespread acceptance under certain circumstances including the inability to perform a trial in humans. 5 However, some scientists, clinicians, and policy makers are not willing to consider modeling studies as definitive evidence to support clinical decisions among individuals or policy making at the population level. The China study was conducted in a single country in a high-risk population, so generalizability is a consideration. Thus, some might hesitate to embrace these 2 studies as pivotal. The ideal follow-up to the China study would be to conduct randomized controlled trials in the general population (as opposed to a high risk group) of various countries. If possible, this approach would satisfy current thinking of regulators on necessary evidence. In the late 20th century and early 21st century, regulatory agencies overseeing cardiovascular medication approval declared that demonstrating improvement in the risk factors ("soft end points") was no longer sufficient to dec -Abstract Truncated-

Suboptimal potassium intake and potential impact on population blood pressure

Effect of Potassium Intake on Blood Pressure:A Dose-Response Meta-Analysis

Global mean potassium intake: a systematic review and Bayesian meta-analysis

The impact of baseline potassium intake on the dose–response relation between sodium reduction and blood pressure change: systematic review and meta-analysis of randomized trials

24-Hour Urinary Sodium and Potassium Excretion and Cardiovascular Risk.

Magnesium and Potassium Supplementation for Systolic Blood Pressure Reduction in the General Normotensive Population: A Systematic Review and Subgroup Meta-Analysis for Optimal Dosage and Treatment Length

Dietary Potassium Attenuates the Effects of Dietary Sodium on Vascular Function in Salt-Resistant Adults

Salt and potassium intake among adult Ghanaians: WHO-SAGE Ghana Wave 3

Differential associations of dietary sodium and potassium intake with blood pressure: a focus on pulse pressure

Urinary Sodium Excretion, Blood Pressure, Cardiovascular Disease, and Mortality: a Community-Level Prospective Epidemiological Cohort Study.

Dietary potassium and the kidney: lifesaving physiology

Potassium-Enriched Salt Substitutes: A Review of Recommendations in Clinical Management Guidelines

A2599 The effect of potassium supplementation on blood pressure in primary hypertension patients: A meta-analysis

Associations of Usual 24-Hour Sodium and Potassium Intakes with Blood Pressure and Risk of Hypertension among Adults in China’s Shandong and Jiangsu Provinces

Does dietary potassium lower blood pressure and protect against coronary heart disease and death? Findings from the Scottish Heart Health Study?

Potassium-Enriched Salt Substitution as a Population Strategy to Prevent Cardiovascular Disease

Potassium status and the risk of type 2 diabetes, cardiovascular diseases, and mortality: a meta-analysis of prospective observational studies

Less sodium and more potassium to reduce cardiovascular risk

Role of dietary potassium and salt substitution in the prevention and management of hypertension

[24 hours urinary sodium and potassium excretion and association with blood pressure among people aged 18-75 years old in six Chinese provinces].

Association between 24-h urinary sodium and potassium excretion and blood pressure among Chinese adults aged 18–69 years